Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines
Open Access
- 1 February 2004
- journal article
- research article
- Published by Springer Nature in Cell Research
- Vol. 14 (1) , 67-73
- https://doi.org/10.1038/sj.cr.7290204
Abstract
We have previously shown a critical role of prolactin (PRL) during maturation and anti-tumor effects of murine natural killer (NK) cells in vitro and in vivo. We extended that study by exploring the ability of human NK cell lines (NK-92 and YT cell) to express PRL receptor (PRL-R) and to respond to PRL stimulation in vitro. Both human NK cell lines constitutively expressed PRL-R on membrane and mRNA transcripts, NK-92 cells contained higher level of PRL-R than YT cells, which correlated to the enhanced capacity of the cells to proliferate and to lyse target cells in response to PRL stimulation in the presence of trace amount of IL-2 or IL-15 in vitro. Two differences between IL-2 and IL-15 in functioning on human NK cells were for the first time observed. PRL synergized with IL-15 to improve proliferation of NK cells in a dose-dependent manner without double peak manifesting like IL-2. Although PRL enhanced the cytotoxicity of IL-2 or IL-15 activated NK cells, it exerted the function through up-regulating gene expression of perforin without influence of FasL in IL-2-stimulated NK cells, while in IL-15-stimulated NK cells, PRL did the function through up-regulating gene expression of both perforin and FasL but not IFNγ. PRL increased expressions of IL-2Rα on membrane and of IL-2 mRNA in cells, indicating that PRL up-regulated NK cell function by improving positive feedback between IL-2 and IL-2R. The similar results were also observed in network between IL-15 and IL-15R. These data indicate a potential role of PRL in human NK cell modulation.Keywords
This publication has 21 references indexed in Scilit:
- Recombinant Human Prolactin Improves Antitumor Effects of Murine Natural Killer Cells in vitro and in vivoNeuroimmunomodulation, 2002
- Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic functionJournal of Neuroimmunology, 2000
- Effects of Growth Hormone and Prolactin on HematopoiesisLeukemia & Lymphoma, 2000
- Up-modulation of interferon-γ mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cellsImmunology, 1999
- Recombinant Human Growth Hormone Promotes Hematopoietic Reconstitution after Syngeneic Bone Marrow Transplantation in MiceThe International Journal of Cell Cloning, 1998
- Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretionBiomedicine & Pharmacotherapy, 1997
- Prolactin receptor gene expression in rat splenocytes and thymocytes during oestrous cycle, pregnancy and lactationCell Proliferation, 1997
- Endocrine, paracrine and autocrine actions of prolactin on immune cellsLife Sciences, 1996
- Effects of growth hormone and prolactin immune development and functionLife Sciences, 1995
- Hyperprolactinemia inhibits natural killer (NK) cell functionin vivo and its bromocriptine treatment not only corrects it but makes it more efficientJournal of Clinical Immunology, 1992